FIRST LINE OF SUBCUTANEOUS ANTI-TNF THERAPY FOR RHEUMATOID ARTHRITIS: A PROSPECTIVE COHORT STUDY-Reference-Cited by-同舟云学术

FIRST LINE OF SUBCUTANEOUS ANTI-TNF THERAPY FOR RHEUMATOID ARTHRITIS: A PROSPECTIVE COHORT STUDY

Published:2020-12-01 Issue:12 Volume:16 Page:1217-1225
ISSN:1744-666X
Container-title:Expert Review of Clinical Immunology
language:en
Short-container-title:Expert Review of Clinical Immunology

Author:

Dos Santos Jéssica Barreto Ribeiro¹²,da Silva Michael Ruberson Ribeiro¹²^ORCID,Kakehasi Adriana Maria³,Acurcio Franciscode Assis²³^ORCID,Almeida Alessandra Maciel²⁴,Alves de Oliveira Junior Haliton⁵^ORCID,Pimenta Pedro Ricardo Kömel²,Alvares-Teodoro Juliana²

Affiliation:

1. Health Assessment, Technology, and Economy Group, Center for Exact, Natural and Health Sciences, Federal University of Espírito Santo, Alegre, Brazil

2. Department of Social Pharmacy, College of Pharmacy, Federal University of Minas Gerais, President Antônio Carlos Avenue, 6627, Campus Pampulha, Belo Horizonte, Brazil

3. Medicine School, Federal University of Minas Gerais, Belo Horizonte, Brazil

4. Faculty of Medical Sciences of Minas Gerais, Belo Horizonte, Brasil

5. Health Technology Assessment Unit, Hospital Alemão Oswaldo Cruz, São Paulo, Brazil

Funder

National Council for Scientific and Technological Development

FAPEMIG

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/1744666X.2021.1850271

Reference43 articles.

1. Rheumatoid arthritis

2. Burden of rheumatoid arthritis on patients’ work productivity and quality of life

3. Brazil. Ministry of Health. Portaria n. 2981, de 26 de novembro de 2009. Aprova o Componente Especializado da Assistência Farmacêutica [Ordinance no. 2981, 2009 Nov 26. Approves the Specialized Component of Pharmaceutical Assistance]. Brazil, 2009.

4. Brazil. Ministry of Health. Portaria conjunta nº 5, de 16 de março de 2020. Aprova o Protocolo Clínico e Diretrizes Terapêuticas da Artrite Reumatoide e Artrite Idiopática Juvenil [Joint Ordinance no. 5, 2020 Mar 16. Approves the Clinical Protocol and Therapeutic Guidelines for Rheumatoid Arthritis and Juvenile Idiopathic Arthritis]. Brazil, 2020.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanisms of Tripterygium wilfordii Hook F on treating rheumatoid arthritis explored by network pharmacology analysis and molecular docking;Open Medicine;2024-01-01

2. First-line biologic therapy with tumor necrosis factor inhibitors for psoriatic arthritis: a prospective observational study;Sao Paulo Medical Journal;2022-12

3. Economic evaluation of adalimumab versus etanercept for psoriatic arthritis in a Brazilian real-world model;Expert Review of Pharmacoeconomics & Outcomes Research;2021-02-09